Literature DB >> 1891717

Viral persistence in neurons explained by lack of major histocompatibility class I expression.

E Joly1, L Mucke, M B Oldstone.   

Abstract

Viruses frequently persist in neurons, suggesting that these cells can evade immune surveillance. In a mouse model, 5 x 10(6) cytotoxic T lymphocytes (CTLs), specific for lymphocytic choriomeningitis virus (LCMV), did not lyse infected neurons or cause immunopathologic injury. In contrast, intracerebral injection of less than 10(3) CTL caused disease and death when viral antigens were expressed on leptomeningeal and choroid plexus cells of the nervous system. The neuronal cell line OBL21 expresses little or no major histocompatibility (MHC) class I surface glycoproteins and when infected with LCMV, resisted lysis by virus-specific CTLs. Expression of MHC heavy chain messenger RNA was limited, but beta 2-microglobulin messenger RNA and protein was made normally. OBL21 cells were made sensitive to CTL lysis by transfection with a fusion gene encoding another MHC class I molecule. Hence, neuronal cells probably evade immune surveillance by failing to express MHC class I molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891717     DOI: 10.1126/science.1891717

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  122 in total

1.  Cell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivo.

Authors:  R A Pereira; A Simmons
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  T cells in the central nervous system: the delicate balance between viral clearance and disease.

Authors:  Dorian B McGavern; Dirk Homann; Michael B A Oldstone
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

3.  Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo.

Authors:  Dorian B McGavern; Urs Christen; Michael B A Oldstone
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

4.  Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease.

Authors:  J E Gairin; M B Oldstone
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 5.  Future trends in neurovirology: neuronal survival during virus infection and analysis of virus-specific T cells in central nervous system tissues.

Authors:  Michael B A Oldstone
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

6.  The Anatomy of a Career in Science.

Authors:  Michael B A Oldstone
Journal:  DNA Cell Biol       Date:  2016-02-02       Impact factor: 3.311

7.  Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy.

Authors:  Fredrik Aronsson; Charlotta Lannebo; Martin Paucar; Johan Brask; Krister Kristensson; Håkan Karlsson
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

8.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells.

Authors:  D D Sedmak; S Chaiwiriyakul; D A Knight; W J Waldmann
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented.

Authors:  Nathalie Escande-Beillard; Lorraine Washburn; Dan Zekzer; Zhongqi-Phyllis Wu; Shoshy Eitan; Sonja Ivkovic; Yuxin Lu; Hoa Dang; Blake Middleton; Tina V Bilousova; Yoshitaka Yoshimura; Christopher J Evans; Sebastian Joyce; Jide Tian; Daniel L Kaufman
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.